unguisin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10652700 |
| MeSH ID | M0561804 |
| Synonym |
|---|
| unguisin a |
| cyclo(d-alanyl-d-tryptophyl-4-aminobutanoyl-d-alanyl-d-valyl-l-phenylalanyl-d-valyl) |
| 226956-06-5 |
| (3r,6r,9r,12s,15r,18r)-12-benzyl-3-(1h-indol-3-ylmethyl)-6,18-dimethyl-9,15-di(propan-2-yl)-1,4,7,10,13,16,19-heptazacyclotricosane-2,5,8,11,14,17,20-heptone |
Unguisin A (1) is a marine-derived, GABA-containing cyclic heptapeptide.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Unguisin A (1) is a marine-derived, GABA-containing cyclic heptapeptide. " | ( Cyclic peptide unguisin A is an anion receptor with high affinity for phosphate and pyrophosphate. Daryl Ariawan, A; Gale, PA; Howe, EN; Hunter, L; Thordarson, P; Webb, JE, 2017) | 2.25 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||